ACADIA Pharmaceuticals Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $66.9M | 10,281 | 68.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17.2M | 6,830 | 17.6% |
| Consulting Fee | $6.8M | 2,302 | 7.0% |
| Food and Beverage | $3.7M | 148,008 | 3.8% |
| Travel and Lodging | $2.3M | 8,965 | 2.4% |
| Grant | $1.1M | 28 | 1.1% |
| Education | $23,289 | 3,408 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $2,000 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| ACP-103-046 | $7.1M | 12 | 469 |
| ACP-2566-003 | $4.2M | 15 | 648 |
| ACP-103-059 | $4.1M | 3 | 393 |
| ACP-103-047 | $4.0M | 10 | 415 |
| ACP-103-045 | $3.8M | 25 | 428 |
| ACP-044-004 | $3.8M | 0 | 68 |
| ACP-103-069 | $3.5M | 0 | 270 |
| ACP-103-042 | $3.4M | 32 | 534 |
| ACP-2566-004 | $2.7M | 0 | 302 |
| ACP-044-005 | $2.4M | 0 | 361 |
| ACP-204-006 | $2.2M | 0 | 482 |
| ACP-103-055 | $2.0M | 1 | 392 |
| ACA 16-cAC-0001 | $1.9M | 77 | 452 |
| ACP-103-070 | $1.8M | 0 | 280 |
| ACP-103-050 | $1.7M | 0 | 37 |
| ACP-103-034 | $1.6M | 50 | 1,157 |
| ACP-2566-005 | $1.6M | 0 | 245 |
| ACP-103-040 | $1.6M | 1 | 21 |
| ACP-103-053 | $1.5M | 0 | 5 |
| ACP-101-302 | $1.5M | 0 | 67 |
| ACP-103-038 | $1.2M | 38 | 588 |
| ACP-103-063 | $1.2M | 7 | 313 |
| ACP-103-035 | $1.2M | 49 | 813 |
| ACP-103-048 | $965,547 | 19 | 177 |
| ACP-103-032 | $933,376 | 33 | 257 |
| ACP-101-303 | $862,294 | 0 | 25 |
| ACP-2566-009 | $794,964 | 0 | 95 |
| ACP-103-033 | $642,060 | 20 | 184 |
| ACP-103-056 | $538,299 | 10 | 178 |
| ACP-103-049 | $490,402 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2017 |
|---|---|---|---|---|
| Dr. Martin Kankam, Md, MD | Internal Medicine | Leavenworth, KS | $1.8M | $0 |
| Esther Yoon, M.d, M.D | Family Medicine | Glendale, CA | $1.1M | $0 |
| Dr. Stuart Isaacson, Md, MD | Neurology | Boca Raton, FL | $997,289 | $0 |
| Dr. David Kreitzman, M.d, M.D | Neurology | Commack, NY | $680,863 | $0 |
| Dr. Mazhar Khowaja | Psychiatry | Houston, TX | $652,119 | $0 |
| Dr. Jason Kellogg, M.d, M.D | Psychiatry | Irvine, CA | $635,909 | $0 |
| Dr. Fahd Amjad, Md, MD | Neurology | Washington, DC | $610,565 | $0 |
| Dr. Cherian Karunapuzha, Md, MD | Neurology | Oklahoma City, OK | $568,423 | $0 |
| Dr. Daniel Cannone, D.o, D.O | Geriatric Medicine | Wadsworth, OH | $553,585 | $0 |
| Neal Hermanowicz, Md, MD | Neurology | Newport Beach, CA | $524,087 | $0 |
| Sarah Atkinson, Md, MD | General Practice | Rochester, NY | $510,156 | $0 |
| Dr. Gustavo Alva, M.d, M.D | Psychiatry | Orange, CA | $479,966 | $0 |
| Dr. Daniel Kremens, M.d., J.d, M.D., J.D | Neurology | Philadelphia, PA | $456,901 | $0 |
| Paul Schulz, M.d, M.D | Neurology | Houston, TX | $448,801 | $0 |
| Jason Caplan, Md, MD | Psychosomatic Medicine | Phoenix, AZ | $376,269 | $0 |
| Marc Cantillon, M.d, M.D | Psychiatry | Livingston, NJ | $375,012 | $0 |
| Dr. Laxman Bahroo, D.o,, D.O, | Neurology | Washington, DC | $367,173 | $0 |
| Dr. Edward Swanton, M.d, M.D | Psychiatry | Lutherville, MD | $360,486 | $0 |
| Khashayar Dashtipour, M.d, M.D | Neurology | Loma Linda, CA | $350,964 | $0 |
| Dr. Amita Patel, M.d, M.D | Psychiatry | Dayton, OH | $311,782 | $0 |
| Rajesh Pahwa, M.d, M.D | Neurology | Kansas City, KS | $298,461 | $0 |
| Dr. Albert Riddle, Md, MD | Geriatric Medicine | Haworth, NJ | $298,331 | $0 |
| Dr. Andrew Rosenzweig, Md, MD | Geriatric Psychiatry | Providence, RI | $294,547 | $0 |
| Dr. Robert Fekete, M.d, M.D | Neurology | Hawthorne, NY | $285,321 | $0 |
| Henry Nasrallah, Md, MD | Psychiatry | Cincinnati, OH | $278,156 | $0 |
About ACADIA Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc has made $98.0M in payments to 23,481 healthcare providers, recorded across 179,823 transactions in the CMS Open Payments database. In 2024, the company paid $10.2M. The top product by payment volume is NUPLAZID ($76.2M).
Payments were distributed across 230 medical specialties. The top specialty by payment amount is Neurology ($16.8M to 4,658 doctors).
Payment categories include: Food & Beverage ($3.7M), Consulting ($6.8M), Research ($66.9M), Travel & Lodging ($2.3M).
ACADIA Pharmaceuticals Inc is associated with 6 products in the CMS Open Payments database, including NUPLAZID, ACP-204, and ACP-101.